Standards for clinical trials in sexual dysfunction of women

Research designs and outcomes assessment

Julia R. Heiman, Marsha K. Guess, Kathleen Connell, Arnold Melman, Janet Shibley Hyde, R. Taylor Segraves, Michael G. Wyllie

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Introduction. Clinical trials on sexual dysfunctions in women are limited in spite of the fact that sexual dysfunctions are likely more common in women than in men. Currently there are no medications approved for treatment in women, and limited data on drug efficacy or psychological efficacy in well-controlled studies. Aim. To provide recommendations/guidelines concerning state-of-the-art knowledge for the research design and outcome assessment standards for clinical trials in women's sexual dysfunctions. Methods. An International Consultation in collaboration with the major urology and sexual medicine associations assembled over 200 multidisciplinary experts from 60 countries into 17 committees. Committee members established specific objectives and scopes for various male and female sexual medicine topics. The recommendations concerning state-of-the-art knowledge in the respective sexual medicine topic represent the opinion of experts from five continents developed in a process over a 2-year period. Concerning the Standards for Clinical Trials in Women's Sexual Dysfunctions Committee, there were seven experts from two countries. Main outcome measure. Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation and debate. Results. A comprehensive update was created which included references and recommended guidelines for rationale and design of clinical trials, study populations, outcome assessments, protocol design and implementation, data analysis and reporting, as well as ethical and clinical issues related to sexual dysfunction research. Conclusions. There is a need for more research in developing standards to be used when performing clinical trials and outcomes assessment research in sexual dysfunctions of women.

Original languageEnglish (US)
Pages (from-to)92-97
Number of pages6
JournalJournal of Sexual Medicine
Volume1
Issue number1
DOIs
StatePublished - 2004

Fingerprint

Research Design
Outcome Assessment (Health Care)
Clinical Trials
Medicine
Expert Testimony
Guidelines
Committee Membership
Urology
Research
Ethics
Referral and Consultation
Psychology
Pharmaceutical Preparations
Population
Therapeutics

Keywords

  • Arousal disorders
  • Clinical drug studies in sexual dysfunction
  • Clinical pharmacology
  • Daily diaries
  • Drug development
  • Libido disorders
  • Orgasm disorders
  • Outcome efficacy assessments
  • Per event questionnaires

ASJC Scopus subject areas

  • Urology
  • Obstetrics and Gynecology

Cite this

Heiman, J. R., Guess, M. K., Connell, K., Melman, A., Hyde, J. S., Segraves, R. T., & Wyllie, M. G. (2004). Standards for clinical trials in sexual dysfunction of women: Research designs and outcomes assessment. Journal of Sexual Medicine, 1(1), 92-97. https://doi.org/10.1111/j.1743-6109.2004.10114.x

Standards for clinical trials in sexual dysfunction of women : Research designs and outcomes assessment. / Heiman, Julia R.; Guess, Marsha K.; Connell, Kathleen; Melman, Arnold; Hyde, Janet Shibley; Segraves, R. Taylor; Wyllie, Michael G.

In: Journal of Sexual Medicine, Vol. 1, No. 1, 2004, p. 92-97.

Research output: Contribution to journalArticle

Heiman, JR, Guess, MK, Connell, K, Melman, A, Hyde, JS, Segraves, RT & Wyllie, MG 2004, 'Standards for clinical trials in sexual dysfunction of women: Research designs and outcomes assessment', Journal of Sexual Medicine, vol. 1, no. 1, pp. 92-97. https://doi.org/10.1111/j.1743-6109.2004.10114.x
Heiman, Julia R. ; Guess, Marsha K. ; Connell, Kathleen ; Melman, Arnold ; Hyde, Janet Shibley ; Segraves, R. Taylor ; Wyllie, Michael G. / Standards for clinical trials in sexual dysfunction of women : Research designs and outcomes assessment. In: Journal of Sexual Medicine. 2004 ; Vol. 1, No. 1. pp. 92-97.
@article{3ad14fa6251746ba9f326c0f47b73338,
title = "Standards for clinical trials in sexual dysfunction of women: Research designs and outcomes assessment",
abstract = "Introduction. Clinical trials on sexual dysfunctions in women are limited in spite of the fact that sexual dysfunctions are likely more common in women than in men. Currently there are no medications approved for treatment in women, and limited data on drug efficacy or psychological efficacy in well-controlled studies. Aim. To provide recommendations/guidelines concerning state-of-the-art knowledge for the research design and outcome assessment standards for clinical trials in women's sexual dysfunctions. Methods. An International Consultation in collaboration with the major urology and sexual medicine associations assembled over 200 multidisciplinary experts from 60 countries into 17 committees. Committee members established specific objectives and scopes for various male and female sexual medicine topics. The recommendations concerning state-of-the-art knowledge in the respective sexual medicine topic represent the opinion of experts from five continents developed in a process over a 2-year period. Concerning the Standards for Clinical Trials in Women's Sexual Dysfunctions Committee, there were seven experts from two countries. Main outcome measure. Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation and debate. Results. A comprehensive update was created which included references and recommended guidelines for rationale and design of clinical trials, study populations, outcome assessments, protocol design and implementation, data analysis and reporting, as well as ethical and clinical issues related to sexual dysfunction research. Conclusions. There is a need for more research in developing standards to be used when performing clinical trials and outcomes assessment research in sexual dysfunctions of women.",
keywords = "Arousal disorders, Clinical drug studies in sexual dysfunction, Clinical pharmacology, Daily diaries, Drug development, Libido disorders, Orgasm disorders, Outcome efficacy assessments, Per event questionnaires",
author = "Heiman, {Julia R.} and Guess, {Marsha K.} and Kathleen Connell and Arnold Melman and Hyde, {Janet Shibley} and Segraves, {R. Taylor} and Wyllie, {Michael G.}",
year = "2004",
doi = "10.1111/j.1743-6109.2004.10114.x",
language = "English (US)",
volume = "1",
pages = "92--97",
journal = "Journal of Sexual Medicine",
issn = "1743-6095",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Standards for clinical trials in sexual dysfunction of women

T2 - Research designs and outcomes assessment

AU - Heiman, Julia R.

AU - Guess, Marsha K.

AU - Connell, Kathleen

AU - Melman, Arnold

AU - Hyde, Janet Shibley

AU - Segraves, R. Taylor

AU - Wyllie, Michael G.

PY - 2004

Y1 - 2004

N2 - Introduction. Clinical trials on sexual dysfunctions in women are limited in spite of the fact that sexual dysfunctions are likely more common in women than in men. Currently there are no medications approved for treatment in women, and limited data on drug efficacy or psychological efficacy in well-controlled studies. Aim. To provide recommendations/guidelines concerning state-of-the-art knowledge for the research design and outcome assessment standards for clinical trials in women's sexual dysfunctions. Methods. An International Consultation in collaboration with the major urology and sexual medicine associations assembled over 200 multidisciplinary experts from 60 countries into 17 committees. Committee members established specific objectives and scopes for various male and female sexual medicine topics. The recommendations concerning state-of-the-art knowledge in the respective sexual medicine topic represent the opinion of experts from five continents developed in a process over a 2-year period. Concerning the Standards for Clinical Trials in Women's Sexual Dysfunctions Committee, there were seven experts from two countries. Main outcome measure. Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation and debate. Results. A comprehensive update was created which included references and recommended guidelines for rationale and design of clinical trials, study populations, outcome assessments, protocol design and implementation, data analysis and reporting, as well as ethical and clinical issues related to sexual dysfunction research. Conclusions. There is a need for more research in developing standards to be used when performing clinical trials and outcomes assessment research in sexual dysfunctions of women.

AB - Introduction. Clinical trials on sexual dysfunctions in women are limited in spite of the fact that sexual dysfunctions are likely more common in women than in men. Currently there are no medications approved for treatment in women, and limited data on drug efficacy or psychological efficacy in well-controlled studies. Aim. To provide recommendations/guidelines concerning state-of-the-art knowledge for the research design and outcome assessment standards for clinical trials in women's sexual dysfunctions. Methods. An International Consultation in collaboration with the major urology and sexual medicine associations assembled over 200 multidisciplinary experts from 60 countries into 17 committees. Committee members established specific objectives and scopes for various male and female sexual medicine topics. The recommendations concerning state-of-the-art knowledge in the respective sexual medicine topic represent the opinion of experts from five continents developed in a process over a 2-year period. Concerning the Standards for Clinical Trials in Women's Sexual Dysfunctions Committee, there were seven experts from two countries. Main outcome measure. Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation and debate. Results. A comprehensive update was created which included references and recommended guidelines for rationale and design of clinical trials, study populations, outcome assessments, protocol design and implementation, data analysis and reporting, as well as ethical and clinical issues related to sexual dysfunction research. Conclusions. There is a need for more research in developing standards to be used when performing clinical trials and outcomes assessment research in sexual dysfunctions of women.

KW - Arousal disorders

KW - Clinical drug studies in sexual dysfunction

KW - Clinical pharmacology

KW - Daily diaries

KW - Drug development

KW - Libido disorders

KW - Orgasm disorders

KW - Outcome efficacy assessments

KW - Per event questionnaires

UR - http://www.scopus.com/inward/record.url?scp=15844423831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15844423831&partnerID=8YFLogxK

U2 - 10.1111/j.1743-6109.2004.10114.x

DO - 10.1111/j.1743-6109.2004.10114.x

M3 - Article

VL - 1

SP - 92

EP - 97

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 1

ER -